DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

Press-release

Pharmacia and Pfizer's Celebrex and Merck's Vioxx Will Soon Compete with Second-Generation Selective COX-2 Inhibitors in the Osteoarthritis Drug Market, According to a Decision Resources Study

Pharmacia and Pfizer's Celebrex and Merck's Vioxx Will Soon Compete with Second-Generation Selective COX-2 Inhibitors in the Osteoarthritis Drug Market, According to a Decision Resources Study

All eyes have been on the first selective COX-2 inhibitors, celecoxib (Pharmacia and Pfizer's Celebrex) and rofecoxib (Merck's Vioxx), for the...

READ ARTICLE

Press-release

Decision Resources Study Examines Improvements in Diagnostic Technologies and Clinical Trial Design that May Lead to More-Effective Acute Ischemic Stroke Therapies

Decision Resources Study Examines Improvements in Diagnostic Technologies and Clinical Trial Design that May Lead to More-Effective Acute Ischemic Stroke Therapies

Acute Ischemic Stroke is a new study from Decision Resources, Inc., that examines the significant unmet needs in the management of ischemic stroke...

READ ARTICLE

Press-release

Decision Resources Study Finds Lucrative Opportunities Await Developers of Novel Hormone Replacement Therapies

Decision Resources Study Finds Lucrative Opportunities Await Developers of Novel Hormone Replacement Therapies

The growing number of postmenopausal women worldwide translates into new challenges for clinicians as they strive to help women stay healthy during...

READ ARTICLE

Press-release

Market Dynamics Will Shift as a Wider Variety of Drugs Are Approved to Treat Parkinson's Disease, According to a Decision Resources Study

Market Dynamics Will Shift as a Wider Variety of Drugs Are Approved to Treat Parkinson's Disease, According to a Decision Resources Study

Parkinson's Disease is a new study from Decision Resources, Inc. that identifies areas of opportunity for companies competing in the Parkinson's...

READ ARTICLE

Press-release

Decision Resources Releases Study Illustrates How Pharmaceutical Companies Can Mine Clinical Development Programs for Strategic Product Advantages

Decision Resources Releases Study Illustrates How Pharmaceutical Companies Can Mine Clinical Development Programs for Strategic Product Advantages

Using Clinical Trials to Strategic Advantage is a new DR Report from Decision Resources, Inc., that explains how clinical trials can be invaluable...

READ ARTICLE

Press-release

Decision Resources Study Profiles 39 Companies Developing Innovative Drug Delivery Systems for Biopharmaceuticals

Decision Resources Study Profiles 39 Companies Developing Innovative Drug Delivery Systems for Biopharmaceuticals

Decision Resources, Inc., announces the publication of Emerging Delivery Systems for Biopharmaceuticals, a new DR Report that offers crucial...

READ ARTICLE

Press-release

Decision Resources Study on Post-Myocardial Infarction Finds AstraZeneca's Rosuvastatin May Become the Statin of Choice by 2005

Decision Resources Study on Post-Myocardial Infarction Finds AstraZeneca's Rosuvastatin May Become the Statin of Choice by 2005

Post-Myocardial Infarction is a new study from Decision Resources, Inc., that examines how the need for better and novel cardioprotective agents to...

READ ARTICLE

Press-release

Novel Asthma Therapies and Combination Agents Will Vie for Market Share, According to a Decision Resources Study

Novel Asthma Therapies and Combination Agents Will Vie for Market Share, According to a Decision Resources Study

Asthma is a new Decision Resources study that examines novel drug development efforts arising from a wealth of research into the pathophysiology of...

READ ARTICLE